title: No connection between the level of exposition to statins in the population and the incidence/mortality of acute myocardial infarction: an ecological study based on Sweden's municipalities.
abstract: BACKGROUND
  Randomised controlled trials have shown an excellent preventive effect of statins on ischemic heart disease. Our objective was to investigate if a relation can be detected between acute myocardial infarction- (AMI) mortality or incidence and statin utilisation, for men and women in different age-groups on a population basis.
  
  
  RESULTS
  The utilisation rate of statins increased almost three times for both men and women between 1998 and 2002. During 1998-2000 the incidence of AMI decreased clearly for men but only slightly for women. Mortality decreased from 1998 to 2002. The change in statin utilisation from 1998 to 2000 showed no correlation to the change in AMI mortality from 2000 to 2002. Statin utilisation and AMI- incidence or mortality showed no correlations when adjusting for socio-economic deprivation, antidiabetic drugs and geographic coordinates.
  
  
  CONCLUSIONS
  Despite a widespread and increasing utilisation of statins, no correlation to the incidence or mortality of AMI could be detected. Other factors than increased statin treatment should be analysed especially when discussing the allocation of public resources.
authors: Division of Community Medicine, Department of Medicine and Health Sciences, Faculty of Health Sciences, Linköping University, Linköping, Sweden. staffan.nilsson@lio.se.
authors: Staffan
authors: S
authors: Nilsson
authors: Sigvard
authors: S
authors: Mölstad
authors: Catarina
authors: C
authors: Karlberg
authors: Jan-Erik
authors: JE
authors: Karlsson
authors: Lars-Göran
authors: LG
authors: Persson
references: Eur Heart J. 1991 Mar;12(3):309-14
references: 2040312
references: J Epidemiol Community Health. 1995 Dec;49 Suppl 2:S3-8
references: 8594130
references: Circulation. 2010 Mar 9;121(9):1069-77
references: 20176986
references: BMJ. 2004 Jun 26;328(7455):1519
references: 15213107
references: Lancet. 2000 Jul 1;356(9223):9-16
references: 10892758
references: Lancet. 2005 Oct 8;366(9493):1267-78
references: 16214597
references: Lancet. 1994 Nov 19;344(8934):1383-9
references: 7968073
references: J Epidemiol Community Health. 2004 Aug;58(8):705-9
references: 15252076
references: Int J Epidemiol. 2003 Jun;32(3):367-74
references: 12777421
references: JAMA. 2004 May 12;291(18):2243-52
references: 15138247
references: N Engl J Med. 1995 Nov 16;333(20):1301-7
references: 7566020
references: J Am Coll Cardiol. 2000 Sep;36(3):959-69
references: 10987628
references: BMJ. 2005 Sep 17;331(7517):614
references: 16107431
references: Am J Epidemiol. 1988 May;127(5):893-904
references: 3282433
references: Eur J Clin Pharmacol. 1999 Mar;55(1):69-76
references: 10206088
references: J Intern Med. 1991 Dec;230(6):479-85
references: 1748856
references: JAMA. 2002 Jul 24-31;288(4):462-7
references: 12132976
references: J Intern Med. 2000 Aug;248(2):159-64
references: 10947895